Sanara MedTech (SMTI) Competitors $33.66 -0.07 (-0.21%) Closing price 04:00 PM EasternExtended Trading$33.64 -0.02 (-0.07%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. PLSE, MDXG, INMD, KMTS, IRMD, TNDM, EMBC, BBNX, SIBN, and AXGNShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include Pulse Biosciences (PLSE), MiMedx Group (MDXG), InMode (INMD), Kestra Medical Technologies (KMTS), iRadimed (IRMD), Tandem Diabetes Care (TNDM), Embecta (EMBC), Beta Bionics (BBNX), SiBone (SIBN), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Its Competitors Pulse Biosciences MiMedx Group InMode Kestra Medical Technologies iRadimed Tandem Diabetes Care Embecta Beta Bionics SiBone AxoGen Sanara MedTech (NASDAQ:SMTI) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. Which has stronger valuation & earnings, SMTI or PLSE? Sanara MedTech has higher revenue and earnings than Pulse Biosciences. Sanara MedTech is trading at a lower price-to-earnings ratio than Pulse Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M3.46-$9.66M-$1.16-29.02Pulse Biosciences$700K1,493.62-$53.58M-$1.05-14.80 Is SMTI or PLSE more profitable? Pulse Biosciences has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.22%. Sanara MedTech's return on equity of -26.43% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.22% -26.43% -10.69% Pulse Biosciences N/A -63.19%-54.98% Does the media refer more to SMTI or PLSE? In the previous week, Sanara MedTech had 2 more articles in the media than Pulse Biosciences. MarketBeat recorded 3 mentions for Sanara MedTech and 1 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 1.36 beat Sanara MedTech's score of 0.72 indicating that Pulse Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Sanara MedTech Positive Pulse Biosciences Positive Do insiders and institutionals have more ownership in SMTI or PLSE? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are held by institutional investors. 42.6% of Sanara MedTech shares are held by company insiders. Comparatively, 71.5% of Pulse Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more volatility & risk, SMTI or PLSE? Sanara MedTech has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500. Do analysts recommend SMTI or PLSE? Sanara MedTech currently has a consensus target price of $50.00, suggesting a potential upside of 48.54%. Pulse Biosciences has a consensus target price of $22.00, suggesting a potential upside of 41.57%. Given Sanara MedTech's higher probable upside, equities analysts clearly believe Sanara MedTech is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryPulse Biosciences beats Sanara MedTech on 8 of the 15 factors compared between the two stocks. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$300.28M$10.97B$5.69B$9.86BDividend YieldN/A1.86%3.99%4.02%P/E Ratio-29.0221.7979.6626.58Price / Sales3.4631.82536.52112.00Price / CashN/A24.7237.7059.65Price / Book8.463.4810.576.59Net Income-$9.66M$211.94M$3.27B$265.83M7 Day Performance-0.85%1.47%0.61%0.18%1 Month Performance34.53%13.45%5.43%2.13%1 Year Performance-5.21%-7.11%50.37%21.07% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech1.9775 of 5 stars$33.66-0.2%$50.00+48.5%-1.2%$300.28M$86.67M-29.0260PLSEPulse Biosciences3.9711 of 5 stars$16.91+2.5%$22.00+30.1%-14.9%$1.13B$700K-16.03140MDXGMiMedx Group3.6675 of 5 stars$7.13+0.6%$12.00+68.4%+8.6%$1.05B$363.77M33.65870Positive NewsINMDInMode2.2318 of 5 stars$14.58-1.5%$18.04+23.7%-4.7%$926.34M$394.82M5.93480Positive NewsKMTSKestra Medical Technologies1.2593 of 5 stars$17.72-4.6%$27.33+54.3%N/A$909.92M$59.81M0.00300News CoveragePositive NewsLockup ExpirationIRMDiRadimed4.7276 of 5 stars$71.88-1.1%$72.00+0.2%+52.9%$909.42M$73.24M44.13110TNDMTandem Diabetes Care4.5811 of 5 stars$12.17+2.0%$22.47+84.6%-73.4%$837.19M$940.20M-4.012,650Positive NewsEMBCEmbecta4.7405 of 5 stars$14.38+0.8%$19.00+32.2%-5.9%$835.88M$1.12B9.992,100News CoveragePositive NewsAnalyst UpgradeBBNXBeta Bionics0.8823 of 5 stars$17.45+2.3%$22.56+29.3%N/A$741.16M$78.02M0.00294SIBNSiBone4.4035 of 5 stars$15.97-2.5%$23.67+48.2%+3.5%$707.08M$167.18M-28.46350News CoveragePositive NewsAXGNAxoGen2.4115 of 5 stars$15.00+1.4%$26.00+73.4%+28.2%$685.09M$187.34M-148.89450News Coverage Related Companies and Tools Related Companies Pulse Biosciences Competitors MiMedx Group Competitors InMode Competitors Kestra Medical Technologies Competitors iRadimed Competitors Tandem Diabetes Care Competitors Embecta Competitors Beta Bionics Competitors SiBone Competitors AxoGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access